发明名称 |
Viral complement control proteins for eye disorders |
摘要 |
The present invention provides compositions and methods for treating and/or preventing age related macular degeneration and other conditions involving macular degeneration or choroidal neovascularization. Certain of the compositions comprise a poxvirus complement control protein or a complement binding fragment or variant thereof. Other compositions comprise a poxvirus complement control protein linked to a moiety that binds to a component present on or at the surface of cell or noncellular molecular entity, e.g., a component present in the eye of a subject at risk of or suffering from age related macular degeneration or a related condition or choroidal neovascularization. Certain of the methods comprise administering a poxvirus complement control protein or complement binding fragment or variant thereof to a subject.
|
申请公布号 |
US2006142191(A1) |
申请公布日期 |
2006.06.29 |
申请号 |
US20050247886 |
申请日期 |
2005.10.08 |
申请人 |
POTENTIA PHARMACEUTICALS, INC. |
发明人 |
FRANCOIS CEDRIC;DESCHATELETS PASCAL;OLSON PAUL |
分类号 |
A61K38/16 |
主分类号 |
A61K38/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|